Skip to main content
ANAB
NASDAQ Life Sciences

Officer Dennis Mulroy Files to Sell Additional $1.03M in Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$51.63
Mkt Cap
$1.502B
52W Low
$11.402
52W High
$72.36
52W Position info
353% above low
Off High info
29% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402.

Summary

AnaptysBio officer Dennis Mulroy has filed to sell an additional $1.03 million in company stock, continuing a recent trend of significant insider selling.


Key Events · Ownership and Investor Activity · ANAB

  • Officer Files Intent to Sell

    Dennis Mulroy, an officer, filed a Form 144 to sell 20,000 shares of common stock, valued at approximately $1.03 million.

  • Continuation of Insider Selling

    This filing extends a pattern of significant insider selling by Mulroy, who has sold or filed to sell over $12 million in shares in the last three months.

  • Context of Corporate Actions

    The ongoing insider selling follows the company's recent biopharma spin-off and the announcement of a $100 million share repurchase program.


Analysis · ANAB · Life Sciences

This Form 144 indicates Officer Dennis Mulroy's intent to sell an additional $1.03 million worth of common stock. This is part of a consistent pattern of insider selling by Mulroy, who has filed to sell over $12 million in shares in the last three months. This ongoing distribution by a key officer, following the company's recent spin-off and the announcement of a $100 million share repurchase program, could raise questions about management's long-term conviction despite the company's efforts to return capital to shareholders.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ANAB was trading at $51.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $50.85
Real-time Price: $50.26 info
Change: -$0.590 (-1%) info
Market Cap: $1.503B info
ANAB
Sep 21, 2026, 4:23 PM EDT
Filing Type: 10-KT
Importance Score:
8
Price at Filing: $55.99
Real-time Price: $50.26 info
Change: -$5.73 (-10%) info
Market Cap: $1.503B info
ANAB
Sep 21, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $55.99
Real-time Price: $50.26 info
Change: -$5.73 (-10%) info
Market Cap: $1.503B info
ANAB
Sep 21, 2026, 4:15 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $55.99
Real-time Price: $50.26 info
Change: -$5.73 (-10%) info
Market Cap: $1.503B info
ANAB
Jun 29, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $65.97
Real-time Price: $50.26 info
Change: -$15.71 (-24%) info
Market Cap: $1.503B info